TR199700872A2 - Kompleks lipid' lerin kullanilmasi. - Google Patents
Kompleks lipid' lerin kullanilmasi.Info
- Publication number
- TR199700872A2 TR199700872A2 TR97/00872A TR9700872A TR199700872A2 TR 199700872 A2 TR199700872 A2 TR 199700872A2 TR 97/00872 A TR97/00872 A TR 97/00872A TR 9700872 A TR9700872 A TR 9700872A TR 199700872 A2 TR199700872 A2 TR 199700872A2
- Authority
- TR
- Turkey
- Prior art keywords
- complex lipids
- gastroentestinal
- lins
- lipase
- tract
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
- A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/46—Hydrolases (3)
- A61K38/48—Hydrolases (3) acting on peptide bonds (3.4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Nem etkisi altinda lipolitik aktivitenin azalmasina karsi, sonda vasitasiyla gastroentestinal trakt'in içine devamli olarak akitmaya mahsus sulu çözeltilerin üretilmesi için elverisli olan, lipaz ve proteaz ihtiva eden sindirim enzimi karisimlarinin suda çözülebilen ispençiyari müstahzarlarina stabilize edici katkilar olarak kompleks lipid' lerin, özellikle lesitin' in kullanimi tarif edilmistir.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19634752 | 1996-08-28 | ||
DE19724845A DE19724845A1 (de) | 1996-08-28 | 1997-06-12 | Verwendung von komplexen Lipiden als stabilisierende Zusätze zu pharmazeutischen Zubereitungen von Verdauungsenzymgemischen |
Publications (2)
Publication Number | Publication Date |
---|---|
TR199700872A3 TR199700872A3 (tr) | 1999-04-21 |
TR199700872A2 true TR199700872A2 (tr) | 1999-04-21 |
Family
ID=26028823
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR97/00872A TR199700872A2 (tr) | 1996-08-28 | 1997-08-28 | Kompleks lipid' lerin kullanilmasi. |
Country Status (22)
Country | Link |
---|---|
US (1) | US5993806A (tr) |
EP (1) | EP0826375B1 (tr) |
JP (1) | JP4593697B2 (tr) |
CN (1) | CN1199694C (tr) |
AR (1) | AR008807A1 (tr) |
AT (1) | ATE284225T1 (tr) |
AU (1) | AU722151B2 (tr) |
BR (1) | BR9704554B1 (tr) |
CA (1) | CA2213151C (tr) |
CZ (1) | CZ295329B6 (tr) |
DE (2) | DE19724845A1 (tr) |
DK (1) | DK0826375T3 (tr) |
EE (1) | EE04179B1 (tr) |
ES (1) | ES2235206T3 (tr) |
HK (1) | HK1005224A1 (tr) |
HU (1) | HUP9701437A3 (tr) |
NO (1) | NO973940L (tr) |
NZ (1) | NZ328616A (tr) |
PL (1) | PL190140B1 (tr) |
PT (1) | PT826375E (tr) |
SK (1) | SK284639B6 (tr) |
TR (1) | TR199700872A2 (tr) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6074689A (en) * | 1998-03-10 | 2000-06-13 | Immucell Corporation | Colonic delivery of protein or peptide compositions |
KR100367659B1 (ko) * | 2000-05-08 | 2003-01-14 | 주식회사 바이넥스 | 선택적 안정화제의 첨가에 따른 자가분해(autolysis)를 통한 고역가 판크레아틴의 제조방법 |
GB0019118D0 (en) * | 2000-08-03 | 2000-09-27 | Danisco | Solid phase glycerolysis |
IL155515A0 (en) * | 2000-11-02 | 2003-11-23 | Cilian Ag | Use of enzymes obtained from ciliates as medicaments for promoting digestion |
US20030099626A1 (en) * | 2001-11-20 | 2003-05-29 | Health Education Corporation | Nutrient absorption enhancing compositions and methods |
PT1729797E (pt) | 2004-03-22 | 2008-12-17 | Solvay Pharm Gmbh | Composições farmacêuticas orais de produtos contendo lipase, em particular de pancreatina, contendo tensioactivos |
US7153504B2 (en) * | 2004-07-30 | 2006-12-26 | Can Technologies, Inc. | Stabilized pancreas product |
AU2006269855A1 (en) * | 2005-07-20 | 2007-01-25 | James S. Brophy | Modification of particle morphology to improve product functionality |
BRPI0614914A2 (pt) | 2005-07-29 | 2011-04-19 | Solvay Pharm Gmbh | processos para a fabricação de pó de pancreatina esterilizada |
US11266607B2 (en) | 2005-08-15 | 2022-03-08 | AbbVie Pharmaceuticals GmbH | Process for the manufacture and use of pancreatin micropellet cores |
US9198871B2 (en) | 2005-08-15 | 2015-12-01 | Abbott Products Gmbh | Delayed release pancreatin compositions |
US10072256B2 (en) | 2006-05-22 | 2018-09-11 | Abbott Products Gmbh | Process for separating and determining the viral load in a pancreatin sample |
US20110183050A1 (en) * | 2006-07-20 | 2011-07-28 | Brophy James S | Modification of particle morphology to improve product functionality |
US8444967B2 (en) | 2010-07-09 | 2013-05-21 | Master Supplements, Inc. | Treatment including prebiotic composition for use with probiotics |
US20090130063A1 (en) * | 2007-11-15 | 2009-05-21 | Solvay Pharmaceuticals Gmbh | Process for separating and determining the viral load in a pancreatin sample |
DE102009006594A1 (de) | 2009-01-29 | 2010-08-05 | Nordmark Arzneimittel Gmbh & Co. Kg | Pharmazeutisches Präparat |
JP5970189B2 (ja) * | 2009-01-29 | 2016-08-17 | ノルドマルク・アルツナイミッテル・ゲゼルシヤフト・ミト・ベシュレンクテル・ハフツング・ウント・コンパニー・コマンデイトゲゼルシヤフト | 医薬調製物 |
CL2011002432A1 (es) | 2010-10-01 | 2012-04-20 | Aptalis Pharma Ltd | Composicion que comprende al menos una enzima digestiva y al menos un portador, en donde el portador comprende celulosa microcristalina que tiene un tamaño de particulas mayor que 100 um; una forma de dosificacion; el envase que la contiene; un proceso para preparar la composicion; y sus usos. |
KR20160087794A (ko) | 2013-08-09 | 2016-07-22 | 앨러간 파마슈티컬스 인터내셔널 리미티드 | 장관 투여에 적합한 소화 효소 조성물 |
CA2915671A1 (en) * | 2013-11-05 | 2015-05-14 | Aptalis Pharma Ltd. | High potency pancreatin pharmaceutical compositions |
JP2014193909A (ja) * | 2014-06-04 | 2014-10-09 | Nordmark Arzneimittel Gmbh & Co Kg | 医薬調製物 |
RU2712142C2 (ru) * | 2014-11-05 | 2020-01-24 | Эбботт Лабораторис Гмбх | Способы получения композиций с улучшенным профилем безопасности, содержащих панкреатин, и композиции, пригодные для фармацевтического применения |
WO2016126970A1 (en) | 2015-02-04 | 2016-08-11 | Abbvie Inc. | Pharmaceutical compositions and methods of use thereof to treat pancreatic enzyme insufficiency |
DE102015114862A1 (de) * | 2015-09-04 | 2017-03-09 | Nordmark Arzneimittel Gmbh & Co. Kg | Pharmazeutische Zusammensetzung, enthaltend eine bakterielle Lipase |
DE102015114857A1 (de) | 2015-09-04 | 2017-03-09 | Nordmark Arzneimittel Gmbh & Co. Kg | Getränk, enthaltend eine pharmazeutische Zusammensetzung |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3956483A (en) * | 1968-10-24 | 1976-05-11 | Wilson Pharmaceutical & Chemical Corporation | Preparing pancreatin |
US3991180A (en) * | 1972-03-06 | 1976-11-09 | Rohm And Haas Company | Stabilization of internally administered pancreatic lipase |
DE2512746C3 (de) * | 1975-03-22 | 1980-04-24 | Kali-Chemie Pharma Gmbh, 3000 Hannover | Verfahren zur Herstellung von keimarmem, faserfreiem Pankreatin |
GB1603640A (en) * | 1977-07-20 | 1981-11-25 | Gist Brocades Nv | Enzyme particles |
JPS58148814A (ja) * | 1982-03-01 | 1983-09-05 | Fujimoto Seiyaku Kk | 消化酵素軟カプセル剤 |
JPS59169491A (ja) * | 1983-03-15 | 1984-09-25 | Duskin Franchise Co Ltd | 酵素の安定化法 |
JPH0229950A (ja) * | 1988-07-18 | 1990-01-31 | Nec Corp | 光ディスク |
JP2679852B2 (ja) * | 1989-11-29 | 1997-11-19 | 株式会社サム研究所 | 経口及び局所投与用生物活性蛋白組成物 |
GB9007052D0 (en) * | 1990-03-29 | 1990-05-30 | Skua Investments Ltd | Pharmaceutical formulations |
NZ241359A (en) * | 1991-01-24 | 1994-08-26 | Martek Corp | Supplementation of infant formula by the addition of at least two different polyunsaturated fatty acids obtained from at least two different microbial sources; compositions comprising such oils |
DE4200002A1 (de) * | 1992-01-02 | 1993-07-08 | Rudolf V Dipl Chem Dr Noronha | Reinigungstablette fuer die zahnprothesen |
EP0719133A1 (en) * | 1993-09-15 | 1996-07-03 | Unilever Plc | Skin care method and composition |
JPH09125096A (ja) * | 1995-10-30 | 1997-05-13 | Koei Sangyo:Kk | 液状天然油脂洗剤 |
-
1997
- 1997-06-12 DE DE19724845A patent/DE19724845A1/de not_active Withdrawn
- 1997-07-09 CZ CZ19972184A patent/CZ295329B6/cs not_active IP Right Cessation
- 1997-08-01 AR ARP970103511A patent/AR008807A1/es unknown
- 1997-08-18 CA CA002213151A patent/CA2213151C/en not_active Expired - Fee Related
- 1997-08-20 DE DE1997512108 patent/DE59712108D1/de not_active Expired - Lifetime
- 1997-08-20 EP EP97114330A patent/EP0826375B1/de not_active Expired - Lifetime
- 1997-08-20 AT AT97114330T patent/ATE284225T1/de not_active IP Right Cessation
- 1997-08-20 ES ES97114330T patent/ES2235206T3/es not_active Expired - Lifetime
- 1997-08-20 DK DK97114330T patent/DK0826375T3/da active
- 1997-08-20 PT PT97114330T patent/PT826375E/pt unknown
- 1997-08-22 SK SK1159-97A patent/SK284639B6/sk unknown
- 1997-08-22 US US08/916,325 patent/US5993806A/en not_active Expired - Lifetime
- 1997-08-25 HU HU9701437A patent/HUP9701437A3/hu unknown
- 1997-08-25 JP JP22800897A patent/JP4593697B2/ja not_active Expired - Lifetime
- 1997-08-27 AU AU35309/97A patent/AU722151B2/en not_active Ceased
- 1997-08-27 NZ NZ328616A patent/NZ328616A/xx unknown
- 1997-08-27 CN CNB971177007A patent/CN1199694C/zh not_active Expired - Fee Related
- 1997-08-27 PL PL97321825A patent/PL190140B1/pl unknown
- 1997-08-27 NO NO973940A patent/NO973940L/no not_active Application Discontinuation
- 1997-08-28 TR TR97/00872A patent/TR199700872A2/tr unknown
- 1997-08-28 EE EE9700249A patent/EE04179B1/xx not_active IP Right Cessation
- 1997-08-28 BR BRPI9704554-3A patent/BR9704554B1/pt not_active IP Right Cessation
-
1998
- 1998-04-30 HK HK98103695A patent/HK1005224A1/xx not_active IP Right Cessation
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR199700872A2 (tr) | Kompleks lipid' lerin kullanilmasi. | |
DE69533922D1 (de) | Raumtemperatur-sterilisierungsmittel | |
BR9910251A (pt) | Estimulação hematopoiética | |
Horwitz et al. | Activation of alveolar macrophage collagenase by a neutral protease secreted by the same cell | |
DE69728537D1 (de) | Oleamid-hydrolase-inhibitoren | |
DE69840165D1 (de) | Genkonstrukt das für ein heterologes "prodrug"-aktivierendes enzym und für ein zellgerichtes teil kodiert | |
MX9703063A (es) | Compuestos de ester y acido boronico, su sintesis y usos. | |
ZA9810444B (en) | Use of 9-deoxy-2',9-methano-3-oxa-4,5,6-trinor-3,7-(1',3'interphenylene)-13,14-dihydroprostaglandin F1 to treat peripheral vascular disease | |
IL115199A (en) | Composition comprising a polynucleic acid molecule in a liposome and method using said composition | |
IT8423449A0 (it) | Indicatori stabilizzati per rivelare l'attivita' di enzimi e procedimenti per la loro preparazione ed uso. | |
MY106202A (en) | Saccharin derivatives useful as proteolytic enzyme inhibitors and preparation thereof. | |
BR9405351A (pt) | Ação combinada de endoglucanases e celobioidrolases | |
SE8302268L (sv) | Ny kombination av proteolytiska och lipolytiska enzymer lemplig som tvettkomposition | |
TW337997B (en) | Pharmaceutical preparation containing plasminogen activators | |
JPS57109797A (en) | Preparation of low-molecular weight keratinous substance | |
BG104470A (en) | The use of a mixture of a diol and an alpha-hydroxy acid for the treatment of hyperkeratotic skin diseases | |
DK328684A (da) | Depot-antiphlogistika | |
JPS5630909A (en) | Preparation of keratin hydrolyzate | |
ATE263173T1 (de) | 7-alkyliden cephalosporansäuren und deren verwendungen | |
WO2002074924A3 (en) | Method for measuring serine palmitoyltransferase in mammalian tissue and use thereof | |
SE9002623L (sv) | Vattenhaltig flytande enzymkomposition | |
ATE326520T1 (de) | Teilchen für flüssige zubereitungen | |
IT1294368B1 (it) | Microorganismi inattivati contenenti enzimi digestivi, processo per la loro preparazione e loro uso in campo alimentare | |
SE8102267L (sv) | Forfarande for framstellning av ej koagulerbart blod medelst proteolytiska enzymer och proteinkoncentrat framstellt derur | |
Newman et al. | Neutral proteinase activity in skeletal muscle from thermally injured rats |